Alamar Biosciences, INC Schedule 13D activist filings

Filed when an investor crosses five percent and intends to influence the company — the activist disclosure.

NASDAQ
Sands Capital Life Sciences Pulse Fund II, L.P. reports a 6.1% stake in Alamar Biosciences, Inc. following the passing of board member Ian Ratcliffe.